Skip to main content
SpringerLink
Log in

Melanoma and Other Skin Cancers

  • Chapter
  • First Online:
The Surgery of Childhood Tumors

  • 1369 Accesses

Abstract

Although malignant melanoma of childhood or adolescence is a relatively rare cancer, the incidence has increased substantially in recent decades. Childhood sun exposure is an important causative factor, in association with certain phenotypes. Preventative programmes have been shown to be beneficial in controlling incidence.

Diagnosis may be difficult as many melanomata in children present with an “atypical” appearance. Awareness of the condition and a low threshold for excision of unusual skin lesions may help to achieve early diagnosis which is the key to successful treatment. Adequate surgical treatment remains the mainstay of treatment.

Non-melanoma skin cancers tend to be associated with a specific predisposing lesion or condition. Biopsy for diagnosis and surgery are the keys to management of these lesions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Lange JR, Balch CM. Melanoma in children: heightened awareness of an uncommon but often curable malignancy. Pediatrics. 2005;115(3):802–3.

    Article  PubMed  Google Scholar 

  2. Thomas JM, Giblin V. Cure of cutaneous melanoma. BMJ. 2006;332(7548):987–8.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Ferrari A, Bono A, Collini P, Rodolfo M, Santinami M. What do we know about cutaneous melanoma of childhood? Contemp Pediatr. 2006;23(9):42–8.

    Google Scholar 

  4. Aldrink JH, Selim MA, Diesen DL, Johnson J, Pruitt SK, Tyler DS, et al. Pediatric melanoma: a single-institution experience of 150 patients. J Pediatr Surg. 2009;44(8):1514–21.

    Article  PubMed  Google Scholar 

  5. Huynh PM, Grant-Kels JM, Grin CM. Childhood melanoma: update and treatment. Int J Dermatol. 2005;44(9):715–23.

    Article  PubMed  Google Scholar 

  6. Lange JR, Palis BE, Chang DC, Soong SJ, Balch CM. Melanoma in children and teenagers: an analysis of patients from the National Cancer Data Base. J Clin Oncol. 2007;25(11):1363–8.

    Article  PubMed  Google Scholar 

  7. Karlsson P, Boeryd B, Sander B, Westermark P, Rosdahl I. Increasing incidence of cutaneous malignant melanoma in children and adolescents 12-19 years of age in Sweden 1973-92. Acta Derm Venereol. 1998;78(4):289–92.

    Article  CAS  PubMed  Google Scholar 

  8. Strouse JJ, Fears TR, Tucker MA, Wayne AS. Pediatric melanoma: risk factor and survival analysis of the surveillance, epidemiology and end results database. J Clin Oncol. 2005;23(21):4735–41.

    Article  PubMed  Google Scholar 

  9. Whiteman DC, Bray CA, Siskind V, Green AC, Hole DJ, Mackie RM. Changes in the incidence of cutaneous melanoma in the west of Scotland and Queensland, Australia: hope for health promotion? Eur J Cancer Prev. 2008;17(3):243–50.

    Article  PubMed  Google Scholar 

  10. Karlsson PM, Fredrikson M. Cutaneous malignant melanoma in children and adolescents in Sweden, 1993-2002: the increasing trend is broken. Int J Cancer. 2007;121(2):323–8.

    Article  CAS  PubMed  Google Scholar 

  11. Whiteman DC, Valery P, McWhirter W, Green AC. Risk factors for childhood melanoma in Queensland. Aust Int J Cancer. 1997;70(1):26–31.

    Article  CAS  Google Scholar 

  12. MacKie RM. Risk factors for the development of primary cutaneous malignant melanoma. Dermatol Clin. 2002;20(4):597–600.

    Article  PubMed  Google Scholar 

  13. Schaffer JV. Pigmented lesions in children: when to worry. Curr Opin Pediatr. 2007;19(4):430–40.

    Article  PubMed  Google Scholar 

  14. Whiteman D, Valery P, McWhirter W, Green A. Incidence of cutaneous childhood melanoma in Queensland. Aust Int J Cancer. 1995;63(6):765–8.

    Article  CAS  Google Scholar 

  15. Gibbs P, Moore A, Robinson W, Walsh P, Golitz L, Gonzalez R. Pediatric melanoma: are recent advances in the management of adult melanoma relevant to the pediatric population. J Pediatr Hematol Oncol. 2000;22(5):428–32.

    Article  CAS  PubMed  Google Scholar 

  16. Zaal LH, Mooi WJ, Klip H, van der Horst CM. Risk of malignant transformation of congenital melanocytic nevi: a retrospective nationwide study from The Netherlands. Plast Reconstr Surg. 2005;116(7):1902–9.

    Article  CAS  PubMed  Google Scholar 

  17. Hale EK, Stein J, Ben-Porat L, Panageas KS, Eichenbaum MS, Marghoob AA, et al. Association of melanoma and neurocutaneous melanocytosis with large congenital melanocytic naevi – results from the NYU-LCMN registry. Br J Dermatol. 2005;152(3):512–7.

    Article  CAS  PubMed  Google Scholar 

  18. Bett BJ. Large or multiple congenital melanocytic nevi: occurrence of cutaneous melanoma in 1008 persons. J Am Acad Dermatol. 2005;52(5):793–7.

    Article  PubMed  Google Scholar 

  19. Ka VS, Dusza SW, Halpern AC, Marghoob AA. The association between large congenital melanocytic naevi and cutaneous melanoma: preliminary findings from an Internet-based registry of 379 patients. Melanoma Res. 2005;15(1):61–7.

    Article  PubMed  Google Scholar 

  20. Kinsler VA, Chong WK, Aylett SE, Atherton DJ. Complications of congenital melanocytic naevi in children: analysis of 16 years’ experience and clinical practice. Br J Dermatol. 2008;159(4):907–14.

    Article  CAS  PubMed  Google Scholar 

  21. Kinsler V, Bulstrode N. The role of surgery in the management of congenital melanocytic naevi in children: a perspective from Great Ormond Street Hospital. J Plast Reconstr Aesthet Surg. 2009;62(5):595–601.

    Article  PubMed  Google Scholar 

  22. Arneja JS, Gosain AK. Giant congenital melanocytic nevi. Plast Reconstr Surg. 2007;120(2):26e–40.

    Article  PubMed  CAS  Google Scholar 

  23. Livestro DP, Kaine EM, Michaelson JS, Mihm MC, Haluska FG, Muzikansky A, et al. Melanoma in the young: differences and similarities with adult melanoma: a case-matched controlled analysis. Cancer. 2007;110(3):614–24.

    Article  PubMed  Google Scholar 

  24. Hussussian CJ, Struewing JP, Goldstein AM, Higgins PA, Ally DS, Sheahan MD, et al. Germline p16 mutations in familial melanoma. Nat Genet. 1994;8(1):15–21.

    Article  CAS  PubMed  Google Scholar 

  25. Pho L, Grossman D, Leachman SA. Melanoma genetics: a review of genetic factors and clinical phenotypes in familial melanoma. Curr Opin Oncol. 2006;18(2):173–9.

    Article  CAS  PubMed  Google Scholar 

  26. Udayakumar D, Tsao H. Melanoma genetics: an update on risk-associated genes. Hematol Oncol Clin North Am. 2009;23(3):415–29, vii.

    Article  PubMed  Google Scholar 

  27. Pappo AS. Melanoma in children and adolescents. Eur J Cancer. 2003;39(18):2651–61.

    Article  CAS  PubMed  Google Scholar 

  28. Tsao H, Zhang X, Kwitkiwski K, Finkelstein DM, Sober AJ, Haluska FG. Low prevalence of germline CDKN2A and CDK4 mutations in patients with early-onset melanoma. Arch Dermatol. 2000;136(9):1118–22.

    Article  CAS  PubMed  Google Scholar 

  29. Clark Jr WH, Elder DE, Guerry D, Epstein MN, Greene MH, Van Horn M. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Hum Pathol. 1984;15(12):1147–65.

    Article  PubMed  Google Scholar 

  30. Miller AJ, Mihm Jr MC. Melanoma. N Engl J Med. 2006;355(1):51–65.

    Article  CAS  PubMed  Google Scholar 

  31. Breen T MPH. Melanoma in children and adolescents. Diagn Histoplathol. 2008;14:18–27.

    Google Scholar 

  32. Lee DA, Cohen JA, Twaddell WS, Palacios G, Gill M, Levit E, et al. Are all melanomas the same? Spitzoid melanoma is a distinct subtype of melanoma. Cancer. 2006;106(4):907–13.

    Article  PubMed  Google Scholar 

  33. Leman JA, Evans A, Mooi W, MacKie RM. Outcomes and pathological review of a cohort of children with melanoma. Br J Dermatol. 2005;152(6):1321–3.

    Article  CAS  PubMed  Google Scholar 

  34. Handfield-Jones SE, Smith NP. Malignant melanoma in childhood. Br J Dermatol. 1996;134(4):607–16.

    Article  CAS  PubMed  Google Scholar 

  35. Spatz A, Avril MF. Melanoma in childhood: review and perspectives. Pediatr Dev Pathol. 1998;1(6):463–74.

    Article  CAS  PubMed  Google Scholar 

  36. Wechsler J, Bastuji-Garin S, Spatz A, Bailly C, Cribier B, Andrac-Meyer L, et al. Reliability of the histopathologic diagnosis of malignant melanoma in childhood. Arch Dermatol. 2002;138(5):625–8.

    Article  PubMed  Google Scholar 

  37. Lyon VB. The spitz nevus: review and update. Clin Plast Surg. 2009;37(1):21–33.

    Article  Google Scholar 

  38. Barnhill RL. Childhood melanoma. Semin Diagn Pathol. 1998;15(3):189–94.

    CAS  PubMed  Google Scholar 

  39. Granter SR, McKee PH, Calonje E, Mihm Jr MC, Busam K. Melanoma associated with blue nevus and melanoma mimicking cellular blue nevus: a clinicopathologic study of 10 cases on the spectrum of so-called ‘malignant blue nevus’. Am J Surg Pathol. 2001;25(3):316–23.

    Article  CAS  PubMed  Google Scholar 

  40. Antony FC, Sanclemente G, Shaikh H, Trelles AS, Calonje E. Pigment synthesizing melanoma (so-called animal type melanoma): a clinicopathological study of 14 cases of a poorly known distinctive variant of melanoma. Histopathology. 2006;48(6):754–62.

    Article  CAS  PubMed  Google Scholar 

  41. Ferrari A, Bono A, Baldi M, Collini P, Casanova M, Pennacchioli E, et al. Does melanoma behave differently in younger children than in adults? A retrospective study of 33 cases of childhood melanoma from a single institution. Pediatrics. 2005;115(3):649–54.

    Article  PubMed  Google Scholar 

  42. Rigel DS, Friedman RJ, Kopf AW, Polsky D. ABCDE – an evolving concept in the early detection of melanoma. Arch Dermatol. 2005;141(8):1032–4.

    Article  PubMed  Google Scholar 

  43. Mackie RM, Doherty VR. Seven-point checklist for melanoma. Clin Exp Dermatol. 1991;16(2):151–3.

    Article  CAS  PubMed  Google Scholar 

  44. Zangari A, Bernardini ML, Tallarico R, Ilari M, Giangiacomi M, Offidani AM, et al. Indications for excision of nevi and melanoma diagnosed in a pediatric surgical unit. J Pediatr Surg. 2007;42(8):1412–6.

    Article  PubMed  Google Scholar 

  45. Breslow A. Tumor thickness in evaluating prognosis of cutaneous melanoma. Ann Surg. 1978;187(4):440.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27(36):6199–206.

    Article  PubMed  PubMed Central  Google Scholar 

  47. McGovern VJ, Mihm Jr MC, Bailly C, Booth JC, Clark Jr WH, Cochran AJ, et al. The classification of malignant melanoma and its histologic reporting. Cancer. 1973;32(6):1446–57.

    Article  CAS  PubMed  Google Scholar 

  48. Saenz NC, Saenz-Badillos J, Busam K, LaQuaglia MP, Corbally M, Brady MS. Childhood melanoma survival. Cancer. 1999;85(3):750–4.

    Article  CAS  PubMed  Google Scholar 

  49. Marsden JR, Newton-Bishop JA, Burrows L, Cook M, Corrie PG, Cox NH, et al. Revised UK guidelines for the management of cutaneous melanoma 2010. J Plast Reconstr Aesthet Surg. 2010;63(9):1401–19.

    Article  CAS  PubMed  Google Scholar 

  50. Sawyer A, McGoldrick RB, Mackey SP, Allan R, Powell B. Does staging computered tomography change management in thick malignant melanoma? J Plast Reconstr Aesthet Surg. 2009;62(4):453–6.

    Article  PubMed  Google Scholar 

  51. Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg. 1970;172(5):902–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Sladden MJ, Balch C, Barzilai DA, Berg D, Freiman A, Handiside T, et al. Surgical excision margins for primary cutaneous melanoma. Cochrane Database Syst Rev. 2009;(4):CD004835.

    Google Scholar 

  53. Thomas JM. Caution with sentinel node biopsy in cutaneous melanoma. Br J Surg. 2006;93(2):129–30.

    Article  CAS  PubMed  Google Scholar 

  54. Thompson JF, Shaw HM. Benefits of sentinel node biopsy for melanoma: a review based on interim results of the first Multicenter Selective Lymphadenectomy Trial. ANZ J Surg. 2006;76(3):100–3.

    Article  CAS  PubMed  Google Scholar 

  55. Howman-Giles R, Shaw HM, Scolyer RA, Murali R, Wilmott J, McCarthy SW, et al. Sentinel lymph node biopsy in pediatric and adolescent cutaneous melanoma patients. Ann Surg Oncol. 2009;17(1):138–43.

    Article  PubMed  Google Scholar 

  56. Mu E, Lange JR, Strouse JJ. Comparison of the use and results of sentinel lymph node biopsy in children and young adults with melanoma. Cancer. 2012;118(10):2700–7.

    Article  PubMed  Google Scholar 

  57. Drepper H, Biess B, Hofherr B, Hundeiker M, Lippold A, Otto F, et al. The prognosis of patients with stage III melanoma. Prospective long-term study of 286 patients of the Fachklinik Hornheide. Cancer. 1993;71(4):1239–46.

    Article  CAS  PubMed  Google Scholar 

  58. Kirkwood JM, Manola J, Ibrahim J, Sondak V, Ernstoff MS, Rao U. A pooled analysis of eastern cooperative oncology group and intergroup trials of adjuvant high-dose interferon for melanoma. Clin Cancer Res. 2004;10(5):1670–7.

    Article  CAS  PubMed  Google Scholar 

  59. Chao MM, Schwartz JL, Wechsler DS, Thornburg CD, Griffith KA, Williams JA. High-risk surgically resected pediatric melanoma and adjuvant interferon therapy. Pediatr Blood Cancer. 2005;44(5):441–8.

    Article  PubMed  Google Scholar 

  60. Shah NC, Gerstle JT, Stuart M, Winter C, Pappo A. Use of sentinel lymph node biopsy and high-dose interferon in pediatric patients with high-risk melanoma: the Hospital for Sick Children experience. J Pediatr Hematol Oncol. 2006;28(8):496–500.

    Article  PubMed  Google Scholar 

  61. Hayes FA, Green AA. Malignant melanoma in childhood: clinical course and response to chemotherapy. J Clin Oncol. 1984;2(11):1229–34.

    CAS  PubMed  Google Scholar 

  62. Boddie Jr AW, Cangir A. Adjuvant and neoadjuvant chemotherapy with dacarbazine in high-risk childhood melanoma. Cancer. 1987;60(8):1720–3.

    Article  PubMed  Google Scholar 

  63. Burmeister BH, Henderson MA, Ainslie J, Fisher R, Di Iulio J, Smithers BM, et al. Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial. Lancet Oncol. 2012;13(6):589–97.

    Article  PubMed  Google Scholar 

  64. Ko CB, Walton S, Keczkes K, Bury HP, Nicholson C. The emerging epidemic of skin cancer. Br J Dermatol. 1994;130(3):269–72.

    Article  CAS  PubMed  Google Scholar 

  65. Glass AG, Hoover RN. The emerging epidemic of melanoma and squamous cell skin cancer. JAMA. 1989;262(15):2097–100.

    Article  CAS  PubMed  Google Scholar 

  66. Swanbeck G, Hillstrom L. Analysis of etiological factors of squamous cell skin cancer of different locations. 4. Concluding remarks. Acta Derm Venereol. 1971;51(2):151–6.

    CAS  PubMed  Google Scholar 

  67. Motley R, Kersey P, Lawrence C. Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. Br J Dermatol. 2002;146(1):18–25.

    Article  CAS  PubMed  Google Scholar 

  68. Christenson LJ, Borrowman TA, Vachon CM, Tollefson MM, Otley CC, Weaver AL, et al. Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years. JAMA. 2005;294(6):681–90.

    Article  CAS  PubMed  Google Scholar 

  69. Stiller CA, Allen MB, Eatock EM. Childhood cancer in Britain: the National Registry of Childhood Tumours and incidence rates 1978-1987. Eur J Cancer. 1995;31A(12):2028–34.

    Article  CAS  PubMed  Google Scholar 

  70. Pearce MS, Parker L, Cotterill SJ, Gordon PM, Craft AW. Skin cancer in children and young adults: 28 years’ experience from the Northern Region Young Person’s Malignant Disease Registry. UK Melanoma Res. 2003;13(4):421–6.

    Article  PubMed  Google Scholar 

  71. Scottish Health Statistics. ISD Scotland; 2012 [cited 2012 14 June 2012]; Available from: www.show.scot.nhs.uk/isd/cancer/cancer.htm.

  72. Lo Muzio L. Nevoid basal cell carcinoma syndrome (Gorlin syndrome). Orphanet J Rare Dis. 2008;3:32.

    Article  PubMed  PubMed Central  Google Scholar 

  73. Richards FM, Goudie DR, Cooper WN, Jene Q, Barroso I, Wicking C, et al. Mapping the multiple self-healing squamous epithelioma (MSSE) gene and investigation of xeroderma pigmentosum group A (XPA) and PATCHED (PTCH) as candidate genes. Hum Genet. 1997;101(3):317–22.

    Article  CAS  PubMed  Google Scholar 

  74. Boutet N, Bignon YJ, Drouin-Garraud V, Sarda P, Longy M, Lacombe D, et al. Spectrum of PTCH1 mutations in French patients with Gorlin syndrome. J Invest Dermatol. 2003;121(3):478–81.

    Article  CAS  PubMed  Google Scholar 

  75. Goldstein AM, Bale SJ, Peck GL, DiGiovanna JJ. Sun exposure and basal cell carcinomas in the nevoid basal cell carcinoma syndrome. J Am Acad Dermatol. 1993;29(1):34–41.

    Article  CAS  PubMed  Google Scholar 

  76. Androphy EJ, Dvoretzky I, Lowy DR. X-linked inheritance of epidermodysplasia verruciformis. Genetic and virologic studies of a kindred. Arch Dermatol. 1985;121(7):864–8.

    Article  CAS  PubMed  Google Scholar 

  77. Sun XK, Chen JF, Xu AE. A homozygous nonsense mutation in the EVER2 gene leads to epidermodysplasia verruciformis. Clin Exp Dermatol. 2005;30(5):573–4.

    Article  PubMed  Google Scholar 

  78. Patel T, Morrison LK, Rady P, Tyring S. Epidermodysplasia verruciformis and susceptibility to HPV. Dis Markers. 2010;29(3–4):199–206.

    Article  PubMed  PubMed Central  Google Scholar 

  79. Majewski S, Jablonska S. Epidermodysplasia verruciformis as a model of human papillomavirus-induced genetic cancer of the skin. Arch Dermatol. 1995;131(11):1312–8.

    Article  CAS  PubMed  Google Scholar 

  80. Sterling JC. Human papillomaviruses and skin cancer. J Clin Virol. 2005;32 Suppl 1:S67–71.

    Article  CAS  PubMed  Google Scholar 

  81. McDermott DF, Gammon B, Snijders PJ, Mbata I, Phifer B, Howland Hartley A, et al. Autosomal dominant epidermodysplasia verruciformis lacking a known EVER1 or EVER2 mutation. Pediatr Dermatol. 2009;26(3):306–10.

    Article  PubMed  PubMed Central  Google Scholar 

  82. Ramoz N, Rueda LA, Bouadjar B, Montoya LS, Orth G, Favre M. Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat Genet. 2002;32(4):579–81.

    Article  CAS  PubMed  Google Scholar 

  83. Lazarczyk M, Pons C, Mendoza JA, Cassonnet P, Jacob Y, Favre M. Regulation of cellular zinc balance as a potential mechanism of EVER-mediated protection against pathogenesis by cutaneous oncogenic human papillomaviruses. J Exp Med. 2008;205(1):35–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  84. Kraemer KH, Lee MM, Andrews AD, Lambert WC. The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm. Arch Dermatol. 1994;130(8):1018–21.

    Article  CAS  PubMed  Google Scholar 

  85. Cartault F, Nava C, Malbrunot AC, Munier P, Hebert JC, N’Guyen P, et al. A new XPC gene splicing mutation has lead to the highest worldwide prevalence of xeroderma pigmentosum in black Mahori patients. DNA Repair (Amst). 2011;10(6):577–85.

    Article  CAS  Google Scholar 

  86. Takebe H, Miki Y, Kozuka T, Furuyama JI, Tanaka K. DNA repair characteristics and skin cancers of xeroderma pigmentosum patients in Japan. Cancer Res. 1977;37(2):490–5.

    CAS  PubMed  Google Scholar 

  87. Kleijer WJ, Laugel V, Berneburg M, Nardo T, Fawcett H, Gratchev A, et al. Incidence of DNA repair deficiency disorders in western Europe: Xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy. DNA Repair (Amst). 2008;7(5):744–50.

    Article  CAS  Google Scholar 

  88. Lehmann AR, McGibbon D, Stefanini M. Xeroderma pigmentosum. Orphanet J Rare Dis. 2011;6:70.

    Article  PubMed  PubMed Central  Google Scholar 

  89. Oetting WS. Albinism. Curr Opin Pediatr. 1999;11(6):565–71.

    Article  CAS  PubMed  Google Scholar 

  90. Summers CG. Albinism: classification, clinical characteristics, and recent findings. Optom Vis Sci. 2009;86(6):659–62.

    Article  PubMed  Google Scholar 

  91. Evans CD, Warin RP. Multiple self-healing epitheliomata (Ferguson Smith). Br J Dermatol. 1961;73:421.

    Article  CAS  PubMed  Google Scholar 

  92. Smith F, Saniman PD. Diagnosis: multiple self-healing epitheliomata. Br J Dermatol. 1952;64(7–8):297–8.

    CAS  PubMed  Google Scholar 

  93. Goudie DR, Yuille MA, Leversha MA, Furlong RA, Carter NP, Lush MJ, et al. Multiple self-healing squamous epitheliomata (ESS1) mapped to chromosome 9q22-q31 in families with common ancestry. Nat Genet. 1993;3(2):165–9.

    Article  CAS  PubMed  Google Scholar 

  94. Dunkin CS, Abouzeid M, Sarangapani K. Malignant transformation in congenital sebaceous naevi in childhood. J R Coll Surg Edinb. 2001;46(5):303–6.

    CAS  PubMed  Google Scholar 

  95. Cribier B, Scrivener Y, Grosshans E. Tumors arising in nevus sebaceus: a study of 596 cases. J Am Acad Dermatol. 2000;42(2 Pt 1):263–8.

    Article  CAS  PubMed  Google Scholar 

  96. Mays SR, Cohen PR. Emerging dermatologic issues in the oncology patient. Semin Cutan Med Surg. 2006;25(4):179–89.

    Article  CAS  PubMed  Google Scholar 

  97. Debray D, Baudouin V, Lacaille F, Charbit M, Rivet C, Harambat J, et al. De novo malignancy after solid organ transplantation in children. Transplant Proc. 2009;41(2):674–5.

    Article  CAS  PubMed  Google Scholar 

  98. Berg D, Otley CC. Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management. J Am Acad Dermatol. 2002;47(1):1–17; quiz 18–20.

    Article  PubMed  Google Scholar 

  99. Maclean H, Dhillon B, Ironside J. Squamous cell carcinoma of the eyelid and the acquired immunodeficiency syndrome. Am J Ophthalmol. 1996;121(2):219–21.

    Article  CAS  PubMed  Google Scholar 

  100. Maurer TA, Christian KV, Kerschmann RL, Berzin B, Palefsky JM, Payne D, et al. Cutaneous squamous cell carcinoma in human immunodeficiency virus-infected patients. A study of epidemiologic risk factors, human papillomavirus, and p53 expression. Arch Dermatol. 1997;133(5):577–83.

    Article  CAS  PubMed  Google Scholar 

  101. Epstein EH. Basal cell carcinomas: attack of the hedgehog. Nat Rev Cancer. 2008;8(10):743–54.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  102. Zhang H, Ping XL, Lee PK, Wu XL, Yao YJ, Zhang MJ, et al. Role of PTCH and p53 genes in early-onset basal cell carcinoma. Am J Pathol. 2001;158(2):381–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  103. Xie J, Murone M, Luoh SM, Ryan A, Gu Q, Zhang C, et al. Activating Smoothened mutations in sporadic basal-cell carcinoma. Nature. 1998;391(6662):90–2.

    Article  CAS  PubMed  Google Scholar 

  104. Marghoob AA, Marghoob AA. Skin cancers and their etiologies. Semin Cutan Med Surg [Review]. 2011;30(4 Suppl):S1–5.

    Article  CAS  Google Scholar 

  105. Schuller DE, Berg JW, Sherman G, Krause CJ. Cutaneous basosquamous carcinoma of the head and neck: a comparative analysis. Otolaryngol Head Neck Surg. 1979;87(4):420–7.

    Article  CAS  PubMed  Google Scholar 

  106. Borel DM. Cutaneous basosquamous carcinoma. Review of the literature and report of 35 cases. Arch Pathol. 1973;95(5):293–7.

    CAS  PubMed  Google Scholar 

  107. Riefkohl R, Wittels B, McCarty K. Metastatic basal cell carcinoma. Ann Plast Surg. 1984;13(6):525–8.

    Article  CAS  PubMed  Google Scholar 

  108. Griffiths RW, Suvarna SK, Stone J. Basal cell carcinoma histological clearance margins: an analysis of 1539 conventionally excised tumours. Wider still and deeper? J Plast Reconstr Aesthet Surg. 2007;60(1):41–7.

    Article  CAS  PubMed  Google Scholar 

  109. Telfer NR, Colver GB, Morton CA. Guidelines for the management of basal cell carcinoma. Br J Dermatol. 2008;159(1):35–48.

    Article  CAS  PubMed  Google Scholar 

  110. Breuninger H, Dietz K. Prediction of subclinical tumor infiltration in basal cell carcinoma. J Dermatol Surg Oncol. 1991;17(7):574–8.

    Article  CAS  PubMed  Google Scholar 

  111. Al-Othman MO, Mendenhall WM, Amdur RJ. Radiotherapy alone for clinical T4 skin carcinoma of the head and neck with surgery reserved for salvage. Am J Otolaryngol. 2001;22(6):387–90.

    Article  CAS  PubMed  Google Scholar 

  112. Rio E, Bardet E, Ferron C, Peuvrel P, Supiot S, Campion L, et al. Interstitial brachytherapy of periorificial skin carcinomas of the face: a retrospective study of 97 cases. Int J Radiat Oncol Biol Phys. 2005;63(3):753–7.

    Article  PubMed  Google Scholar 

  113. Kwan W, Wilson D, Moravan V. Radiotherapy for locally advanced basal cell and squamous cell carcinomas of the skin. Int J Radiat Oncol Biol Phys. 2004;60(2):406–11.

    Article  PubMed  Google Scholar 

  114. Childers BJ, Goldwyn RM, Ramos D, Chaffey J, Harris JR. Long-term results of irradiation for basal cell carcinoma of the skin of the nose. Plast Reconstr Surg. 1994;93(6):1169–73.

    Article  CAS  PubMed  Google Scholar 

  115. Caccialanza M, Piccinno R, Grammatica A. Radiotherapy of recurrent basal and squamous cell skin carcinomas: a study of 249 re-treated carcinomas in 229 patients. Eur J Dermatol. 2001;11(1):25–8.

    CAS  PubMed  Google Scholar 

  116. Guix B, Finestres F, Tello J, Palma C, Martinez A, Guix J, et al. Treatment of skin carcinomas of the face by high-dose-rate brachytherapy and custom-made surface molds. Int J Radiat Oncol Biol Phys. 2000;47(1):95–102.

    Article  CAS  PubMed  Google Scholar 

  117. Morton CA, McKenna KE, Rhodes LE. Guidelines for topical photodynamic therapy: update. Br J Dermatol. 2008;159(6):1245–66.

    Article  CAS  PubMed  Google Scholar 

  118. Morton CA, Brown SB, Collins S, Ibbotson S, Jenkinson H, Kurwa H, et al. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br J Dermatol. 2002;146(4):552–67.

    Article  CAS  PubMed  Google Scholar 

  119. Nikkels AF, Pierard-Franchimont C, Nikkels-Tassoudji N, Bourguignon R, Pierard GE. Photodynamic therapy and imiquimod immunotherapy for basal cell carcinomas. Acta Clin Belg. 2005;60(5):227–34.

    Article  CAS  PubMed  Google Scholar 

  120. Varma S, Wilson H, Kurwa HA, Gambles B, Charman C, Pearse AD, et al. Bowen’s disease, solar keratoses and superficial basal cell carcinomas treated by photodynamic therapy using a large-field incoherent light source. Br J Dermatol. 2001;144(3):567–74.

    Article  CAS  PubMed  Google Scholar 

  121. Clark C, Bryden A, Dawe R, Moseley H, Ferguson J, Ibbotson SH. Topical 5-aminolaevulinic acid photodynamic therapy for cutaneous lesions: outcome and comparison of light sources. Photodermatol Photoimmunol Photomed. 2003;19(3):134–41.

    Article  CAS  PubMed  Google Scholar 

  122. Gollnick H, Barona CG, Frank RG, Ruzicka T, Megahed M, Tebbs V, et al. Recurrence rate of superficial basal cell carcinoma following successful treatment with imiquimod 5 % cream: interim 2-year results from an ongoing 5-year follow-up study in Europe. Eur J Dermatol. 2005;15(5):374–81.

    CAS  PubMed  Google Scholar 

  123. Schulze HJ, Cribier B, Requena L, Reifenberger J, Ferrandiz C, Garcia Diez A, et al. Imiquimod 5 % cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe. Br J Dermatol. 2005;152(5):939–47.

    Article  CAS  PubMed  Google Scholar 

  124. Vidal D, Matias-Guiu X, Alomar A. Fifty-five basal cell carcinomas treated with topical imiquimod: outcome at 5-year follow-up. Arch Dermatol. 2007;143(2):266–8.

    Article  PubMed  Google Scholar 

  125. Ziegler A, Jonason AS, Leffell DJ, Simon JA, Sharma HW, Kimmelman J, et al. Sunburn and p53 in the onset of skin cancer. Nature. 1994;372(6508):773–6.

    Article  CAS  PubMed  Google Scholar 

  126. Brash DE. Roles of the transcription factor p53 in keratinocyte carcinomas. Br J Dermatol. 2006;154 Suppl 1:8–10.

    Article  CAS  PubMed  Google Scholar 

  127. Brown VL, Harwood CA, Crook T, Cronin JG, Kelsell DP, Proby CM. p16INK4a and p14ARF tumor suppressor genes are commonly inactivated in cutaneous squamous cell carcinoma. J Invest Dermatol. 2004;122(5):1284–92.

    Article  CAS  PubMed  Google Scholar 

  128. Katiyar SK. UV-induced immune suppression and photocarcinogenesis: chemoprevention by dietary botanical agents. Cancer Lett. 2007;255(1):1–11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  129. Salehi Z, Mashayekhi F, Shahosseini F. Significance of eIF4E expression in skin squamous cell carcinoma. Cell Biol Int. 2007;31(11):1400–4.

    Article  CAS  PubMed  Google Scholar 

  130. Breuninger H, Black B, Rassner G. Microstaging of squamous cell carcinomas. Am J Clin Pathol. 1990;94(5):624–7.

    Article  CAS  PubMed  Google Scholar 

  131. Friedman HI, Cooper PH, Wanebo HJ. Prognostic and therapeutic use of microstaging of cutaneous squamous cell carcinoma of the trunk and extremities. Cancer. 1985;56(5):1099–105.

    Article  CAS  PubMed  Google Scholar 

  132. Rowe DE, Carroll RJ, Day Jr CL. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol. 1992;26(6):976–90.

    Article  CAS  PubMed  Google Scholar 

  133. van den Brekel MW, Stel HV, Castelijns JA, Croll GJ, Snow GB. Lymph node staging in patients with clinically negative neck examinations by ultrasound and ultrasound-guided aspiration cytology. Am J Surg. 1991;162(4):362–6.

    Article  PubMed  Google Scholar 

  134. Sumi M, Ohki M, Nakamura T. Comparison of sonography and CT for differentiating benign from malignant cervical lymph nodes in patients with squamous cell carcinoma of the head and neck. AJR Am J Roentgenol. 2001;176(4):1019–24.

    Article  CAS  PubMed  Google Scholar 

  135. Motley R, Kersey P, Lawrence C. Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. Br J Plast Surg. 2003;56(2):85–91.

    Article  CAS  PubMed  Google Scholar 

  136. Seidler AM, Bramlette TB, Washington CV, Szeto H, Chen SC. Mohs versus traditional surgical excision for facial and auricular nonmelanoma skin cancer: an analysis of cost-effectiveness. Dermatol Surg. 2009;35(11):1776–87.

    Article  CAS  PubMed  Google Scholar 

  137. Robins P, Dzubow LM, Rigel DS. Squamous-cell carcinoma treated by Mohs’ surgery: an experience with 414 cases in a period of 15 years. J Dermatol Surg Oncol. 1981;7(10):800–1.

    Article  CAS  PubMed  Google Scholar 

  138. Ross AS, Schmults CD. Sentinel lymph node biopsy in cutaneous squamous cell carcinoma: a systematic review of the English literature. Dermatol Surg. 2006;32(11):1309–21.

    CAS  PubMed  Google Scholar 

  139. Veness M, Richards S. Role of modern radiotherapy in treating skin cancer. Australas J Dermatol. 2003;44(3):159–66; quiz 167–8.

    Article  PubMed  Google Scholar 

  140. Iqbal CW, St Peter S, Ishitani MB. Pediatric dermatofibrosarcoma protuberans: multi-institutional outcomes. J Surg Res. 2011;170(1):69–72.

    Article  PubMed  Google Scholar 

  141. Dimitropoulos VA. Dermatofibrosarcoma protuberans. Dermatol Ther. 2008;21(6):428–32.

    Article  PubMed  Google Scholar 

  142. Kikuchi K, Soma Y, Fujimoto M, Kadono T, Sato S, Abe M, et al. Dermatofibrosarcoma protuberans: increased growth response to platelet-derived growth factor BB in cell culture. Biochem Biophys Res Commun. 1993;196(1):409–15.

    Article  CAS  PubMed  Google Scholar 

  143. Simon MP, Pedeutour F, Sirvent N, Grosgeorge J, Minoletti F, Coindre JM, et al. Deregulation of the platelet-derived growth factor B-chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell fibroblastoma. Nat Genet. 1997;15(1):95–8.

    Article  CAS  PubMed  Google Scholar 

  144. Shimizu A, O’Brien KP, Sjoblom T, Pietras K, Buchdunger E, Collins VP, et al. The dermatofibrosarcoma protuberans-associated collagen type I alpha1/platelet-derived growth factor (PDGF) B-chain fusion gene generates a transforming protein that is processed to functional PDGF-BB. Cancer Res. 1999;59(15):3719–23.

    CAS  PubMed  Google Scholar 

  145. Heuvel ST, Suurmeijer A, Pras E, Van Ginkel RJ, Hoekstra HJ. Dermatofibrosarcoma protuberans: recurrence is related to the adequacy of surgical margins. Eur J Surg Oncol. 2010;36(1):89–94.

    Article  PubMed  Google Scholar 

  146. Meguerditchian AN, Wang J, Lema B, Kraybill WG, Zeitouni NC, Kane 3rd JM. Wide excision or Mohs micrographic surgery for the treatment of primary dermatofibrosarcoma protuberans. Am J Clin Oncol. 2010;33(3):300–3.

    PubMed  Google Scholar 

  147. Gloster Jr HM, Harris KR, Roenigk RK. A comparison between Mohs micrographic surgery and wide surgical excision for the treatment of dermatofibrosarcoma protuberans. J Am Acad Dermatol. 1996;35(1):82–7.

    PubMed  Google Scholar 

  148. Baum CL, Link BK, Neppalli VT, Swick BL, Liu V. Reappraisal of the provisional entity primary cutaneous CD4+ small/medium pleomorphic T-cell lymphoma: a series of 10 adult and pediatric patients and review of the literature. J Am Acad Dermatol. 2011;65(4):739–48.

    Article  PubMed  Google Scholar 

  149. Williams VL, Torres-Cabala CA, Duvic M. Primary cutaneous small- to medium-sized CD4+ pleomorphic T-cell lymphoma: a retrospective case series and review of the provisional cutaneous lymphoma category. Am J Clin Dermatol. 2011;12(6):389–401.

    Article  PubMed  Google Scholar 

  150. Holden CA, Spittle MF, Jones EW. Angiosarcoma of the face and scalp, prognosis and treatment. Cancer. 1987;59(5):1046–57.

    Article  CAS  PubMed  Google Scholar 

  151. Dehner LP. Juvenile xanthogranulomas in the first two decades of life: a clinicopathologic study of 174 cases with cutaneous and extracutaneous manifestations. Am J Surg Pathol. 2003;27(5):579–93.

    Article  PubMed  Google Scholar 

  152. Mancini AJ, Prieto VG, Smoller BR. Role of cellular proliferation and apoptosis in the growth of xanthogranulomas. Am J Dermatopathol. 1998;20(1):17–21.

    Article  CAS  PubMed  Google Scholar 

  153. Kraus MD, Haley JC, Ruiz R, Essary L, Moran CA, Fletcher CD. “Juvenile” xanthogranuloma: an immunophenotypic study with a reappraisal of histogenesis. Am J Dermatopathol. 2001;23(2):104–11.

    Article  CAS  PubMed  Google Scholar 

  154. Janney CG, Hurt MA, Santa Cruz DJ. Deep juvenile xanthogranuloma. Subcutaneous and intramuscular forms. Am J Surg Pathol. 1991;15(2):150–9.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Canniesburn Unit, Glasgow Royal Infirmary and Royal Hospital for Sick Children, Castle St., Glasgow, G4 0SF, Scotland, UK

    Stuart B. Watson MB, ChB, FRCS (Plast)

Authors
  1. Stuart B. Watson MB, ChB, FRCS (Plast)
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stuart B. Watson MB, ChB, FRCS (Plast) .

Editor information

Editors and Affiliations

  1. Surgical Paediatrics, University of Glasgow, Glasgow, United Kingdom

    Robert Carachi

  2. Indianapolis, Indiana, USA

    Jay L. Grosfeld

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Watson, S.B. (2016). Melanoma and Other Skin Cancers. In: Carachi, R., Grosfeld, J. (eds) The Surgery of Childhood Tumors. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-48590-3_22

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-48590-3_22

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-48588-0

  • Online ISBN: 978-3-662-48590-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation